Inventor · disambiguated record
Vadim Alexandrov
Also filed as: ALEXANDROV VADIM
5 granted patents·5 pending applications·12 citations·filing 2016–2023
73Inventor score
Top patents by PatentIndex Score
10 records- 0189US10336732B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·7 cites·20 claims
- 0281US9758529B2Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Sep 12, 2017·3 cites·54 claims
- 0379US9856238B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·2 cites·33 claims
- 0473US2022185799A11-heterocyclyl isochromanyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0569US11192885B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Dec 7, 2021·0 cites·24 claims
- 0669US2021300942A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0768US2024282411A1Multi-Reference Poly-Conformational Computational Methods for De-Novo Design, Optimization, and Repositioning of Pharmaceutical CompoundsQUANTORI LLC·Filed 2023·Application pending·0 cites
- 0861US2020024286A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0956US2018057506A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1053US11077090B2Compounds and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Aug 3, 2021·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when Vadim Alexandrov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →